HLA-DOA Antikörper (N-Term)
Kurzübersicht für HLA-DOA Antikörper (N-Term) (ABIN1881420)
Target
Alle HLA-DOA Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 31-59, N-Term
-
Aufreinigung
- This antibody is purified through a protein A column, followed by peptide affinity purification.
-
Immunogen
- This HLA-DOA antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 31-59 amino acids from the N-terminal region of human HLA-DOA.
-
Isotyp
- Ig Fraction
-
-
-
-
Applikationshinweise
- WB: 1:1000
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Haltbarkeit
- 6 months
-
-
- HLA-DOA (HLA Class II DO alpha (HLA-DOA))
-
Andere Bezeichnung
- HLA-DOA
-
Hintergrund
- Important modulator in the HLA class II restricted antigen presentation pathway by interaction with the HLA-DM molecule in B-cells. Modifies peptide exchange activity of HLA-DM.
-
Molekulargewicht
- 27599
-
NCBI Accession
- NP_002110
-
UniProt
- P06340
-
Pathways
- Human Leukocyte Antigen (HLA) in Adaptive Immune Response
Target
-